About Polpharma Biologics
Polpharma Biologics is a Healthcare company based in Gdansk (Poland) founded in 2011. It develops and manufactures biosimilar drugs and CDMO services for biotechnology applications. It operates on a B2B and CDMO Services model. Polpharma Biologics offers products and services including Biosimilar Drugs, Cell Lines, and CDMO Services. Its focus areas include Biotechnology, Drug Development, Cell Lines and Biopharmaceuticals. Its legal entity is Polpharma Biologics S.A. Similar companies include Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex and 5 more; 5 of its 10 listed similar companies have raised funding.
Company details
Polpharma Biologics is a biotechnology company specializing in the development and production of biosimilar drugs and innovative molecules. It offers CDMO services for biosimilars, utilizing state-of-the-art facilities in Poland and the Netherlands. The company collaborates with global partners to improve patient access to affordable therapies through research, clinical trials, and manufacturing. Its activities focus on high-quality biologics for various therapeutic areas, ensuring compliance with international standards.
- Headquarters Gdansk, Poland
- SectorsHealthcare
- Email••••••••
- Website polpharmabiologics.com
- Social LinkedIn YouTube
- Legal Name Polpharma Biologics S.A.
Products & Services of Polpharma Biologics
Polpharma Biologics offers a comprehensive portfolio of products and services, including Biosimilar Drugs, Cell Lines, and CDMO Services.
Medications similar to original biologics for cost-effective patient treatments.
Platforms for developing and licensing biosimilar drugs externally.
Customized development and production services for biosimilars and molecules.
Apps and channels of Polpharma Biologics
its YouTube channel Polpharma Biologics has 85 subscribers and 30 videos.
Videos from Polpharma Biologics
The most watched videos on Polpharma Biologics's YouTube channel, Polpharma Biologics (85 subscribers). Click a video to play it here.
More on Polpharma Biologics.
People of Polpharma Biologics
74 people are tracked at Polpharma Biologics (31 in leadership, 43 in team).
| Name | Role | Group |
|---|---|---|
Ruth Blättler-Egli | Head Of People & Organisation | Leadership |
Michał Kruszewski | Head Of Information Security | Leadership |
Theodoros Zografou | Senior Director Business Development | Leadership |
Vinay Kumar | Head Of Quality Compliance & System | Leadership |
Lukasz Krawczyk | Head Of Proposal Management | Leadership |
Jerzy Staraks | President Of The Management Board | Leadership |
Alexandra Moulson | Chief Strategy & Portfolio Officer | Leadership |
Frederic Papp | Chief Technical Officer | Leadership |
Mathieu Ballie | Chief Quality Officer | Leadership |
Anjan Selz | Chief Executive Officer | Leadership |
Karolina Topczewska | Senior Director Global Procurement -management Board Member | Leadership |
Justyna Tyborowska | Chief People Officer | Leadership |
Heni Abida | Sr. Director Strategy & Transformation | Leadership |
MacIej Szerszenowicz | Engineering Director | Leadership |
Ferdi Geerdinck | Director Of Development PMO | Leadership |
Vikram Pundir | Vice President Site Quality And Group Quality Network Strategy | Management Board Member | Leadership |
Hannes Teissl | Chief Business Officer | Leadership |
Michał Szafranko | Head Of IT Quality And Compliance | Leadership |
Jakub Walkowiak | CFO | Leadership |
Iain MacDonald | Director Of Quality | Leadership |
54 more people are available in the full profile.
Complete people profiles for Polpharma Biologics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Polpharma Biologics
Polpharma Biologics has 10 listed similar companies in our database, 5 of them funded. They include Bionova Scientific, Just Biotherapeutics, JHL Biotech, Avid Bioservices and MabPlex, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bionovascientific.com | 2013 | Fremont, United States | $22M | 72 | Mammalian cell culture biologics are developed through contract research services. | |
| justbiotherapeutics.com | 2014 | Seattle, United States | $123.51M | 79 | Designing technologies to accelerate biotherapeutic development and to reduce manufacturing costs | |
| jhlbiotech.com | 2012 | Hsinchu, Taiwan | $186.6M | – | Contract manufacturing solutions for biologics are provided to Asian companies. | |
| avidbio.com | 2002 | Orange, United States | – | 501 | Drug substance development, analytical, and compliance services are provided. | |
| mabplexinc.com | 2013 | Yantai, China | $130M | – | Biologics development and GMP manufacturing services are offered. | |
| probiogen.de | 1994 | Berlin, Germany | – | – | Contract development and manufacturing organization focussed on therapeutic proteins/antibodies, viral vaccines and biosimilars | |
| rentschler-biopharma.com | 1927 | Laupheim, Germany | – | 861 | Full-service CDMO for biopharmaceuticals | |
| agcbio.com | 2018 | Bothell, United States | – | 1,290 | Provides contract development and manufacturing for biopharmaceuticals worldwide. | |
| therapurebio.com | 2008 | Mississauga, Canada | – | – | Complex biologics are developed and manufactured by Therapure Biopharma. | |
| autekbio.com | 2006 | Santa Clara, United States | $101.03M | – | Biopharma CDMO specializing in the production of therapeutic proteins and antibodies from mammalian cell culture. |
Detailed similar companies of Polpharma Biologics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Polpharma Biologics
Websites that share an audience with Polpharma Biologics (polpharmabiologics.com).
Websites whose visitors overlap most with Polpharma Biologics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| aabiot.com | 98% | 7.1K | – | View details | |
| maxygen.com | 85% | 1.7K | #10,660,575 | View details | |
| pumabiotechnology.com | 81% | 9.6K | #2,574,682 | View details | |
| polpharma.pl | 79% | 28.1K | #1,405,803 | View details |
Top companies in Cell Therapy
10 companies that operate in the same segment as Polpharma Biologics (Cell Therapy), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
CAR T-cell and T-cell receptor immunotherapies for cancer are developed. | 2013 | Seattle, Washington, United States | USD 316.67 M | – | 520 | |
CAR-T and TIL immunotherapies for solid tumors are developed. | 2018 | San Francisco, California, United States | USD 493 M | USD 36 K | 233 | |
T-cell-based immunotherapies for cancer treatment are developed. | 2000 | Tubingen, Baden-wurttemberg, Germany | USD 236.4 M | USD 54.47 M | 423 | |
Engineered T-cell immunotherapies are developed for cancer and auto-immune diseases. | 2015 | London, England, United Kingdom | USD 181.37 M | USD 75.56 M | 647 | |
Smart surgical devices for spinal surgery are developed. | 1997 | San Diego, California, United States | USD 54.1 M | – | – | |
Genetically engineered cell therapies are developed for multiple disorders. | 2018 | Seattle, Washington, United States | USD 821 M | – | 253 | |
Provider of bio-artificial pancreas for Type 1 Diabetes treatment | 2015 | Cambridge, Massachusetts, United States | USD 158 M | – | 58 | |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms. | 2011 | San Francisco, California, United States | USD 36.13 M | – | 36 | |
Developer of immune cell therapies | 2019 | San Francisco, California, United States | USD 631.16 M | – | 178 | |
Cue Biopharma is focused on developing immunotherapy solutions. | 2015 | Cambridge, Massachusetts, United States | USD 10 M | USD 27.47 M | 41 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Polpharma Biologics
Complete news archive for Polpharma Biologics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polpharma Biologics
Polpharma Biologics was founded in 2011.
Polpharma Biologics is headquartered in Gdansk, Poland. It is registered at Gdansk, Pomeranian Voivodeship, Poland.
Polpharma Biologics is a biotechnology company specializing in the development and production of biosimilar drugs and innovative molecules. It offers CDMO services for biosimilars, utilizing state-of-the-art facilities in Poland and the Netherlands. The company collaborates with global partners to improve patient access to affordable therapies through research, clinical trials, and manufacturing. Its activities focus on high-quality biologics for various therapeutic areas, ensuring compliance with international standards.
Polpharma Biologics's top competitors include Avid Bioservices, Bionova Scientific and Rentschler Biopharma.
Polpharma Biologics offers Biosimilar Drugs, Cell Lines, and CDMO Services.
Polpharma Biologics operates through Polpharma Biologics S.A..